We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
From 1 July 2022, WIPO Standard ST.26 specifies new requirements for biological sequence listings included in patent applications.
Submit samples for full 16S rRNA genetic sequencing of bacteria for high-resolution identification and taxonomic placement.
Submit samples for tests to identify bacteria isolated from animals or food using 16S rRNA gene sequencing.
In a UK-first, the Medicines and Healthcare products Regulatory Agency (MHRA) and Barts Health NHS Trust have developed a DNA sequencing approach that can be implemented onsite in hospitals so they can diagnose bacterial infections faster and more accurately.
The New Variant Assessment Platform (NVAP) is an offer of UK capacity and expertise to detect and assess new variants of SARS-CoV-2 around the world.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).